Current Dendrimer Applications in Cancer Diagnosis and Therapy

Author(s): Istvan J. Majoros, Christopher R. Williams, James R. Baker Jr.

Journal Name: Current Topics in Medicinal Chemistry

Volume 8 , Issue 14 , 2008

Become EABM
Become Reviewer


In recent years, medicinal chemists have begun to realize that dendrimers may be a keystone in the future of medicine. The field of oncology will soon be revolutionized by novel strategies for diagnosis and therapy employing dendrimer-based nanodevices. In the near future, cancer diagnosis via MRI will be improved by the incorporation of dendrimers as advanced contrast agents. Novel dendrimer-based contrast agents can not only be targeted specifically to cancer cells but may also incorporate a cytotoxic function to induce apoptosis on said cells as well. Dendrimers are being applied to a variety of cancer therapies to improve the safety and effectiveness of many common therapeutics. Investigations into the applicability of dendrimers in photodynamic therapy, boron neutron capture therapy, and gene transfection are also being undertaken. This review will cover the fundamentals of cutting-edge research utilizing dendrimers for cancer diagnosis and therapy. An objective review of these new technologies will detail how dendrimerbased nanodevices are advantageous over conventional medicine.

Keywords: PAMAM dendrimer, drug delivery, cancer diagnosis, cancer therapy, chemotherapy, photodynamic therapy, MRI, apoptosis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [1165 - 1179]
Pages: 15
DOI: 10.2174/156802608785849049
Price: $65

Article Metrics

PDF: 13